Leukemias -

Leukemias

J. Fleischer (Herausgeber)

Buch | Softcover
XVII, 334 Seiten
2011 | 1. Softcover reprint of the original 1st ed. 1993
Springer Berlin (Verlag)
978-3-642-77085-2 (ISBN)
106,99 inkl. MwSt
Current problems in research and treatment of leukemias as discussed at the symposium of the International Society of Haematology on leukemias in Dresden (Germany) are dealt with in detail in this volume. The characterization of leukemic cells and the evaluation of their function are themes, with the first hints emerging of the possibility of relating them to the intensity of treatment required. The cytokines, responsible for cooperation between cells, are also of great importance, and the beginnings of therapeutic applications can be discerned here. Not only are the cytokines themselves very interesting, but also the application of cells producing cytokines according to the range of macrophages found. The emphasis on cell-to-cell relationship is thus a main topic of the book. Of course, other treatment such as bone marrow transplantation and interferon therapy play an important part, too, and the latest results of chemotherapy are reported. A further essential area covered is the diagnosis and therapy of chronic leukemic diseases, the inclusion of which suitably rounds off the book. I am very grateful to the out standing specialists from both the West and the East who contributed to the symposium and this book: an important sign of collaboration and integration for the future.

The Blast Cell of Acute Leukemias.- Prognosis of Myelodysplasic Syndromes.- Megakaryocytopoiesis in Patients with Myelodysplastic Syndromes.- Diversity of Bone Marrow Findings in Chronic Myelomonocytic Leukemia.- Nucleolar Organizer Regions in Acute Leukemia.- A Further Note on the Ultrastructure of Human Leukemic Cells.- Cell Kinetics of Human Acute Leukemia: In Vivo Study with Bromodeoxyuridine and Flow Cytometry.- Clinical, Biochemical and Cytokinetic Parameters for Distinguishing Smouldering and Rapidly Proliferating Variants of Acute Leukemia.- Dimethylsulfoxide and Retinoic Acid-Induced Differentiation and Commitment in HL-60 Cells.- Immunophenotyping of Adult Acute Leukemia by Immuno-Alkaline Phosphatase Labeling.- Diagnostic and Prognostic Value of Immunological Leukemia Phenotyping.- Immunoelectron Microscopy of Megakaryoblasts in Megakaryoblastic Transformation of Chronic Granulocytic Leukemia.- Thymidine Kinase in Leukemic Cells: Significance for Characterization and Follow-Up of Acute Leukemia.- Bleeding Tendency in Acute Promyelocytic Leukemia: Reversal by Cell Differentiation?.- Risk Prediction of Therapy-Induced Leukemia After Cytostatic Treatment.- Cytokines and Macrophages.- The Role of Cytokines in Experimental and Clinical Hematology.- Hematopoietins: New Tools in the Treatment of Hematopoietic Insufficiency.- Interleukin-1 and Tumor Necrosis Factor Production in Acute Nonlymphoid Leukemia.- Interleukin-2: Biological Activities and Clinical Relevance in Advanced Stage Human Cancer.- Interleukin-2 in the Treatment of Cancer Disease: Introduction of a Therapeutic Model and some Immunological Data.- Enhancement of Growth of Murine Colony-Forming Units-Granulocyte-Macrophage at Suboptimal Colony-Stimulating Factor-Granulocyte-Macrophage Concentrations by Nucleosides, Nucleobases and Their Analogues, and the Dimer of the Hemoregulatory Pentapeptide.- Induction of Lymphokine-Activated Killer Cells from Human Leukemic T Cells by Interleukin-2.- The Influence of Recombinant Human Granulocyte-Monocyte-Colony-Stimulating Factor on Stroma Formation by Normal Human Bone Marrow Cells In Vitro.- Adoptive Transfer of Autologous Cytotoxic Macrophages Grown from Blood Monocytes. A New Approach to Cancer Immunotherapy.- Interferon Therapy.- Strategies for Optimizing Cytokine Treatment of Malignancies: Determination of Interferon Sensitivity in Chronic Myelocytic Leukemia.- Clinical Study with Human Recombinant Interferon-?2a in Chronic Myeloid Leukemia. Protocol of the Italian Cooperative Study Group on Chronic Myeloid Leukemia: Preliminary Analysis of Results.- Alpha-Interferon in Hematological Disorders with Special Emphasis on Chronic Myeloid Leukemia.- Long-Term Treatment with Alpha-Interferon of Excessive Thrombocytosis in Myeloproliferative Disorders.- Sustained Remission After Interferon Treatment for Essential Thrombocythemia.- Treatment of Chronic Myeloproliferative Disorders with Interferon-?.- Interferon-? and Hairy Cell Leukemia.- Bone Marrow Transplantation.- Allogeneic Marrow Transplantation for Acute Leukemia.- Allogeneic Bone Marrow Transplantation: State of the Art and Future Directions.- Bone Marrow Transplantation for Leukemia in Europe.- Bone Marrow Transplantation in Acute Leukemias and Chronic Myeloid Leukemia.- Bone Marrow Transplantation for Chronic Myeloid Leukemia in France. Results of the French Cooperative Group.- National and International Experiences with Autologous Bone Marrow Transplantation in Acute Leukemias.- CD48 Monoclonal Antibody K31 for Bone Marrow Transplantation: Functional Characteristics.- Comparison of the Growth of Xenografted Human Bone Marrow with the Growth of Xenografted Acute Myeloid Leukemia Cells and Marrow Repopulating Capacity Following Transplantation into Allogeneic Recipients.- Chemotherapy of Acute Leukemias.- Cellular Pharmacokinetics of Daunomycin in Human Leukemic Blasts In Vitro and In Vivo.- Detection of the Multidrug Resistance Phenotype in Leukemic Cells with an In Vitro Chemosensitivity Assay.- Chemotherapy for Adult Acute Myeloid Leukemia: Study Results from the Acute Myeloid Leukemia Cooperative Group and Overview.- Mitoxantrone and Cytosine Arabinoside as First-Line Therapy in Elderly Patients with Acute Myeloid Leukemia.- Intermediate-Dose Cytosine Arabinoside and Amsacrine for Remission Induction and High-Dose Cytosine Arabinoside and Amsacrine for Intensive Consolidation in Relapsed and Refractory Adult Acute Myelogenous Leukemia.- Aclacinomycin A Therapy in Acute Nonlymphoblastic Leukemia.- Therapy of Blastic Transformation of Chronic Myeloid Leukemia.- Chronic Myeloproliferative Diseases and Chronic Lymphatic Leukemia.- Hanover Classification of Chronic Myeloproliferative Diseases by Histopathology of the Bone Marrow.- Chronic Myeloproliferative Syndromes: Initial Findings, Evolution, and Prognosis in 489 Patients.- Histomorphological and Cytogenetic Investigations in Chronic Myeloproliferative Diseases.- Chronic Megakaryocytic-Granulocytic Myelosis: Accuracy of Clinical Diagnosis of Chronic Myeloproliferative Disorders with Thrombocytosis.- Morphology of Megakaryocytes in Chronic Myeloproliferative Diseases.- The Megakaryocytic Myeloid Leukemia: Clinical, Morphological and Functional Aspects.- Budd-Chiari Syndrome and Other Abdominal Thromboses in the Chronic Myeloproliferative Disorders.- New Therapy of Myelofibrosis with an Antifibrotic Substance and a Macrophage Stimulant.- Preliminary Results of a Multicenter Study of Chronic Myelogenous Leukemia Comparing Busulfan/6-Mercaptopurine with Dibromomannitol/6-Mercaptopurine.- Ag-NOR in B-Cell Chronic Lymphocytic Leukemia: Pathomorphological Subtypes of the Disease.- Flow Cytochemical Analysis of Lymphoid Cells in B-Chronic Lymphocytic Leukemia (B-CLL).- Immunodiagnosis of Leukemic Blood Cells of Patients with Chronic Lymphocytic Leukemia and Other Non-Hodgkin's Lymphomas by Monoclonal Antibodies of the Biowissenschaften Leipzig Series.- Advanced and Terminal Phase of B-Cell Chronic Lymphocytic Leukemia.

Erscheint lt. Verlag 21.12.2011
Zusatzinfo XVII, 334 p.
Verlagsort Berlin
Sprache englisch
Maße 155 x 235 mm
Gewicht 539 g
Themenwelt Medizinische Fachgebiete Innere Medizin Hämatologie
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Schlagworte Chemotherapy • cytokines • Interferon • leukemia • Macrophages • Transplantation
ISBN-10 3-642-77085-1 / 3642770851
ISBN-13 978-3-642-77085-2 / 9783642770852
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Hämatologie und Internistische Onkologie

von Dietmar P. Berger; Monika Engelhardt; Justus Duyster

Buch | Softcover (2023)
ecomed-Storck GmbH (Verlag)
129,99